2022
DOI: 10.1155/2022/4023123
|View full text |Cite
|
Sign up to set email alerts
|

Influence of Information-Based Continuous Care on Disease Control and Treatment Compliance of Elderly Diabetic Patients

Abstract: Background. The incidence of diabetes is increasing year by year. For elderly diabetic patients, poor blood glucose control and worsening immune function greatly increase the risk of complications, which will seriously affect their quality of life. Purpose. This paper primarily clarifies the influence of information-based continuous care on disease control and treatment compliance of elderly diabetic patients. Methods. From December 2018 to December 2021, 106 elderly diabetic patients were selected, and their … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2024
2024
2024
2024

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 21 publications
0
1
0
Order By: Relevance
“…Likewise, a study on the influence of information-based continuous care on disease control and treatment compliance of Chinese elderly diabetic patients reveals that information-based continuous care yields favorable effects on disease control and treatment compliance among elderly diabetic patients. It can assist in managing blood sugar levels and optimizing patients’ self-management capabilities, holding significant clinical value for broader implementation [ 16 ].…”
Section: Introductionmentioning
confidence: 99%
“…Likewise, a study on the influence of information-based continuous care on disease control and treatment compliance of Chinese elderly diabetic patients reveals that information-based continuous care yields favorable effects on disease control and treatment compliance among elderly diabetic patients. It can assist in managing blood sugar levels and optimizing patients’ self-management capabilities, holding significant clinical value for broader implementation [ 16 ].…”
Section: Introductionmentioning
confidence: 99%